South Korea’s KOSPI index fell 1.5% amid foreign selling and AI valuation concerns, while KOSDAQ surged 3.5% on policy hopes and biotech gains as US markets closed for Thanksgiving.
#YonhapInfomax #KOSPI #KOSDAQ #ForeignInvestors #EliLilly #BiotechStocks #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=93090

The KOSDAQ index surged nearly 3% on policy optimism and a biotech rally, outpacing the KOSPI, as investors anticipate government measures to boost the market.
#YonhapInfomax #KOSDAQ #PolicyMeasures #BiotechStocks #EliLilly #InvestorSentiment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=93033

South Korea’s KOSPI closed up 0.25% as shipbuilding stocks surged on merger and export hopes, while KOSDAQ was flat with biotech gains offset by losses in robotics and batteries.
#YonhapInfomax #KOSPI #Shipbuilding #HDHyundai #KOSDAQ #BiotechStocks #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=78944

Asian stock markets rallied as weaker US jobs data fueled expectations of a Federal Reserve rate cut, with major indices in Japan, China, Hong Kong, and Taiwan closing higher. Japanese government bond yields fell, the yuan strengthened, and biotech shares led gains in Hong Kong.
#YonhapInfomax #FederalReserve #Nikkei225 #USJobsData #YuanAppreciation #BiotechStocks #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=75675

🚨 Anthem Biosciences makes a stellar market debut!
📈 Listed at ₹723 — a 27% premium over the IPO price of ₹570.
💰 IPO subscribed 63.86 times!

With a 30% YoY revenue growth and global CRDMO dominance, is Anthem India’s next biotech star?
📊 FY25 Net Profit: ₹451 Cr | EBITDA Margin: 36.8%

🔗 Read the full analysis to know if you should invest.

#AnthemBiosciences #StockMarketIndia #IPOListing #BiotechStocks #CRDMO #PharmaInvesting #AnthemSharePrice https://news24media.org/anthem-biosciences-share-price/

US-China agree to significant tariff reductions, boosting global markets and benefiting semiconductor and biotech sectors, with KOSPI expected to rise gradually.
#YonhapInfomax #USChinaTariffAgreement #StockMarketSurge #SemiconductorSector #BiotechStocks #GlobalTradeRelations #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62891

$HOFV

✅ Float under 4M
✅ Extremely oversold (Stoch under 10)
✅ Bouncing from the same zone it exploded from last time — over 100% move
✅ This stock loves to pop without warning
✅ Holding above strong support… one clean breakout and it’s game on

Smart money positions early. Watch closely.

#SmallCaps #BiotechStocks #NASDAQ

KOSPI falls 0.50% amid US tariff concerns, while KOSDAQ rises 2.02% driven by biotech stocks; markets await US PPI data release
#YonhapInfomax #KOSPI #USTariffs #KOSDAQ #BiotechStocks #ProducerPriceIndex #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=58360

KOSPI falls below 2,300 as US-China trade tensions escalate, with biotech sector hit hard by potential pharmaceutical tariffs
#YonhapInfomax #KOSPI #USTariffs #TradeWar #BiotechStocks #MarketUncertainty #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=57934

KOSPI recovers to 2,480 level as individual investors and pension funds increase buying, while KOSDAQ turns positive led by biotech stocks exempt from reciprocal tariffs, showing market resilience amid U.S.-Korea trade tensions.
#YonhapInfomax #KOSPI #ReciprocalTariffs #BiotechStocks #IndividualInvestors #MarketResilience #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56986

UBS upgrades Cryoport to 'buy' from 'neutral', setting $10 target price amid positive outlook for cell and gene therapy services expansion and expected free cash flow growth
#YonhapInfomax #UBS #Cryoport #InvestmentUpgrade #BiotechStocks #GeneTherapy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=55505